James T Glover
CIK 1231175 · View on SEC EDGAR ↗
First SEC filing: Aug. 23, 2013 · Latest: Aug. 23, 2013
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 13, 2015 | VIVS | P | 10,000 | $2.80 | $28,000 | 10,000 Direct | — | Acquired | -100.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 26, 2018 | VIVS | Stock Option (Right to Buy) | Common Stock (45,550) | $1.29 | July 26, 2028 | 45,500 | Acquired |
| Aug. 24, 2017 | VIVS | Stock Option (Right to Buy) | Common Stock (42,500) | $1.97 | Aug. 24, 2027 | 42,500 | Acquired |
| Aug. 17, 2016 | VIVS | Stock Option (Right to Buy) [F1] | Common Stock (18,500) | $4.35 | Aug. 17, 2025 | 18,500 | Acquired |
| Aug. 20, 2015 | VIVS | Stock Option (Right to Buy) | Common Stock | $2.09 | Aug. 20, 2025 | 37,000 | Acquired |
| Aug. 20, 2014 | VIVS | Stock Option (Right to Buy) | Common Stock (31,500) | $7.62 | Aug. 20, 2024 | 31,500 | Acquired |
| Aug. 21, 2013 | VIVS | Stock Option (Right to Buy) | Common Stock (30,500) | $5.86 | Aug. 21, 2023 | 30,500 | Acquired |
| Oct. 18, 2012 | VIVS | Stock Option (Right to Buy) | Common Stock (17,500) | $2.54 | Oct. 18, 2022 | 17,500 | Acquired |
| Sept. 5, 2012 | VIVS | Stock Option (Right to Buy) | Common Stock (31,500) | $2.23 | Sept. 5, 2022 | 31,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).